Wuhan Andigensil Biotechnology Co., Ltd. is a subsidiary of Wuhan Yuangu Biotechnology Co., Ltd., was founded in 2015, located in Wuhan East Lake New Technology Development Zone. We specialize in the development and production of biological raw materials for IVD and pathological diagnostic. We successfully passed the quality management system certification of ISO13485 in 2019, and registered by China Customs for the export of animal-derived biological raw materials. We have been registered in TRACES of the European Commission, our products are mainly exported to the United States, Australia, Asian and European countries, such as animal serum, animal IgG.

Andigensil aims to provide more choices and help for IVD reagent enterprises to improve product quality. Our core products include immunoblockers, various animal IgG, antigen-affinity chromatography purified secondary antibodies, and constantly introduced diagnostic monoclonal antibodies and recombinant proteins, among which mouse IgG is the most competitive product; We also provide animal immunodiagnostic raw materials, including eukaryotic expression of recombinant antigens, monoclonal antibodies, high-quality secondary antibodies, etc.

In the field of pathological diagnosis, we have developed immunohistochemical testing products in the early stage, and already have a number of independent intellectual property rights, forming a series of patented products such as rapid immunohistochemical testing kits, direct immunohistochemical kits, polymerase labeled antibodies, dewaxing hot repair solution, and immunohistochemical pens, which will be further expanded in other fields of pathological diagnosis in the future.

Andigensil will continue to enrich product series and improve product quality, strive to become an enterprise with distinctive characteristics in the fields of pathological diagnosis and biological raw materials.